Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices ...

A groundbreaking new drug is giving pancreatic cancer patients new hope. The pill got FDA approval Wednesday.

The new targeted therapy is designed to block KRAS, a protein that drives many pancreatic cancers, and its approval ...

On Wednesday, the U.S. Food and Drug Administration announced its approval of Rasonque, a new treatment option for people ...

The Food and Drug Administration’s approval on Wednesday of a new drug for pancreatic cancer marked the end of a long quest ...

The therapy is a brand new targeted drug for the disease which experts have labelled as a substantial breakthrough following ...

The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new ...

The Food and Drug Administration has approved Rasonque, a daily pill for patients with metastatic pancreatic cancer.

The FDA has approved Rasonque (daraxonrasib), a once-daily targeted pill for certain adults with metastatic pancreatic ...

The FDA on Wednesday said it approved the drug, Rasonque, known generically as daraxonrasib, for adults with metastatic ...

The newly approved drug daraxonrasib targets a mutation found in most pancreatic cancer cases, and early patients in South ...

Since last year, pharma companies have announced 24 final-stage trials for medicines targeting the disease.